Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres.

Saved in:
Bibliographic Details
Title: Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres.
Authors: Sanganalmath, P.1, Lester, J.E.1, Bradshaw, A.G.1,2, Das, T.1, Esler, C.3, Roy, A.E.F.4, Toy, E.5, Lester, J.F.6, Button, M.6, Wilson, P.7, Comins, C.7, Atherton, P.2, Pickles, R.2, Foweraker, K.8, Walker, G.A.9, Keni, M.9, Hatton, M.Q.1 matthew.hatton@sth.nhs.uk
Source: Clinical Oncology. Mar2018, Vol. 30 Issue 3, p144-150. 7p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first